fluorescein-5-isothiocyanate has been researched along with cyclosporine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, JM; Schapira, AH; Seaton, TA | 1 |
Fleck, C | 1 |
Balupuri, S; Booth, TA; Gerstenkorn, C; Kirby, JA; Mohamed, MA; Robertson, H; Talbot, D | 1 |
Kasper, RC; LeBoit, PE; Nihal, M; Wood, GS | 1 |
Choy, YM; Fung, KP; Ko, S; Kong, SK; Kwok, TT; Lee, CY; Yuen, WF | 1 |
Schlagwein, N; van der Kooij, SW; van Kooten, C; Woltman, AM | 1 |
Bentley, MV; de Paula, D; Fantini, MC; Ferreira, DA; Garcia, MT; Lopes, LB; Thomazini, JA | 1 |
Feldman, G; Kiely, B; Martin, N; McMorrow, T; Ryan, G; Ryan, MP | 1 |
8 other study(ies) available for fluorescein-5-isothiocyanate and cyclosporine
Article | Year |
---|---|
Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Coloring Agents; Cyclosporine; Dopamine Agents; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; In Situ Nick-End Labeling; Intracellular Membranes; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Parkinson Disease; PC12 Cells; Propidium; Rats; Rotenone; Uncoupling Agents | 1998 |
Determination of the glomerular filtration rate (GFR): methodological problems, age-dependence, consequences of various surgical interventions, and the influence of different drugs and toxic substances.
Topics: Aging; Animals; Cyclosporine; Female; Fluorescein-5-isothiocyanate; Glomerular Filtration Rate; Humans; Inulin; Kidney; Kidney Diseases; Kinetics; Metals; Nephrectomy; Rats; Rats, Wistar; Species Specificity; Uremia | 1999 |
Active TGF-beta1 expression in kidney transplantation: a comparative study of cyclosporin-A (CyA) and tacrolimus (FK506).
Topics: Biopsy; Cyclosporine; Fluorescein-5-isothiocyanate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Microscopy, Confocal; Tacrolimus; Transforming Growth Factor beta | 2000 |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease.
Topics: Adult; Atrophy; Cutis Laxa; Cyclosporine; DNA; Elastic Tissue; Female; Fluorescein-5-isothiocyanate; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunohistochemistry; In Situ Hybridization; Kidney Transplantation; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Polymerase Chain Reaction; RNA, Viral; Skin Neoplasms; Tacrolimus | 2001 |
Hyperthermia and tumour necrosis factor-alpha induced apoptosis via mitochondrial damage.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line; Cyclosporine; Cytochrome c Group; Cytosol; Fever; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Immunosuppressive Agents; Membranes; Mice; Mitochondria; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2000 |
The novel cyclophilin-binding drug sanglifehrin A specifically affects antigen uptake receptor expression and endocytic capacity of human dendritic cells.
Topics: Antigens, CD; Cell Differentiation; Cells, Cultured; Cyclophilins; Cyclosporine; Dendritic Cells; Dextrans; Endocytosis; Fluorescein-5-isothiocyanate; Humans; Immunophenotyping; Immunosuppressive Agents; Lactones; Lectins, C-Type; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mannose; Receptors, Antigen; Receptors, Fc; Receptors, IgG; Serum Albumin; Spiro Compounds; T-Lymphocytes; Up-Regulation | 2004 |
Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.
Topics: Administration, Topical; Animals; Chemistry, Pharmaceutical; Cyclosporine; Dermatologic Agents; Diffusion Chambers, Culture; Drug Carriers; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glycerides; Liquid Crystals; Male; Mice; Mice, Hairless; Nanoparticles; Oleic Acid; Skin; Skin Absorption; Swine; Technology, Pharmaceutical | 2006 |
Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function.
Topics: Animals; Antibodies; Butadienes; Cell Division; Cell Survival; Cyclosporine; Dextrans; Dogs; Electric Impedance; Enzyme Inhibitors; Epithelial Cells; Fluorescein-5-isothiocyanate; Imidazoles; Immunosuppressive Agents; Kidney; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Tight Junctions; Transforming Growth Factor beta1 | 2007 |